35 research outputs found
A statistical framework for cross-tissue transcriptome-wide association analysis
Transcriptome-wide association analysis is a powerful approach to studying the genetic architecture of complex traits. A key component of this approach is to build a model to impute gene expression levels from genotypes by using samples with matched genotypes and gene expression data in a given tissue. However, it is challenging to develop robust and accurate imputation models with a limited sample size for any single tissue. Here, we first introduce a multi-task learning method to jointly impute gene expression in 44 human tissues. Compared with single-tissue methods, our approach achieved an average of 39% improvement in imputation accuracy and generated effective imputation models for an average of 120% more genes. We describe a summary-statistic-based testing framework that combines multiple single-tissue associations into a powerful metric to quantify the overall gene–trait association. We applied our method, called UTMOST (unified test for molecular signatures), to multiple genome-wide-association results and demonstrate its advantages over single-tissue strategies
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele
Modeling psychiatric disorders: from genomic findings to cellular phenotypes
Major programs in psychiatric genetics have identified 4150 risk loci for psychiatric disorders. These loci converge on a small
number of functional pathways, which span conventional diagnostic criteria, suggesting a partly common biology underlying
schizophrenia, autism and other psychiatric disorders. Nevertheless, the cellular phenotypes that capture the fundamental features
of psychiatric disorders have not yet been determined. Recent advances in genetics and stem cell biology offer new prospects for
cell-based modeling of psychiatric disorders. The advent of cell reprogramming and induced pluripotent stem cells (iPSC) provides
an opportunity to translate genetic findings into patient-specific in vitro models. iPSC technology is less than a decade old but holds
great promise for bridging the gaps between patients, genetics and biology. Despite many obvious advantages, iPSC studies still
present multiple challenges. In this expert review, we critically review the challenges for modeling of psychiatric disorders, potential
solutions and how iPSC technology can be used to develop an analytical framework for the evaluation and therapeutic
manipulation of fundamental disease processes